These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16611018)

  • 1. Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective.
    Amacher DE
    Curr Drug Metab; 2006 Apr; 7(3):219-29. PubMed ID: 16611018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology.
    Erve JC
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):923-46. PubMed ID: 17125409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are chemically reactive metabolites responsible for adverse reactions to drugs?
    Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
    Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of new chemical entities with decreased potential for adverse drug reactions.
    Park KB; Dalton-Brown E; Hirst C; Williams DP
    Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three models of free radical-induced cell injury.
    Comporti M
    Chem Biol Interact; 1989; 72(1-2):1-56. PubMed ID: 2684438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicophores: investigations in drug safety.
    Williams DP
    Toxicology; 2006 Sep; 226(1):1-11. PubMed ID: 16860917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.
    Orhan H; Vermeulen NP
    Curr Drug Metab; 2011 May; 12(4):383-94. PubMed ID: 21395525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of reactive intermediates in photoallergic dermatitis.
    Andreu I; Mayorga C; Miranda MA
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):303-8. PubMed ID: 20585243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in drug intolerance.
    Andreu I; Mayorga C; Miranda MA
    Curr Drug Metab; 2009 Nov; 10(9):947-55. PubMed ID: 20214587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.
    Tang W; Lu AY
    Drug Metab Rev; 2010 May; 42(2):225-49. PubMed ID: 19939207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for dealing with reactive intermediates in drug discovery and development.
    Nassar AE; Lopez-Anaya A
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):126-36. PubMed ID: 14982156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions.
    Boelsterli UA
    Curr Drug Metab; 2002 Aug; 3(4):439-50. PubMed ID: 12093359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry, physiology and pathology of free radicals.
    Bergendi L; Benes L; Duracková Z; Ferencik M
    Life Sci; 1999; 65(18-19):1865-74. PubMed ID: 10576429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical mechanism of oxidative damage by redox-cycling drugs.
    Rotilio G; Mavelli I; Rossi L; Ciriolo MR
    Environ Health Perspect; 1985 Dec; 64():259-64. PubMed ID: 3007093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research in the Division of Toxicology. The importance of reactive intermediates of drug biotransformation in drug toxicity.
    Mulder GJ
    Pharm Weekbl Sci; 1985 Apr; 7(2):67-70. PubMed ID: 4000901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions and reactive oxygen species.
    Ganeva MG; Getova DP; Gadjeva VG
    Folia Med (Plovdiv); 2008; 50(1):5-11. PubMed ID: 18543782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity.
    Park BK; Kitteringham NR; Powell H; Pirmohamed M
    Toxicology; 2000 Nov; 153(1-3):39-60. PubMed ID: 11090946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.